1-[3-(Trifluoromethyl)phenyl]-1H-pyrazol-5-amine
|
- $240 - $488
- Product name: 1-[3-(Trifluoromethyl)phenyl]-1H-pyrazol-5-amine
- CAS: 78119-07-0
- MF: C10H8F3N3
- MW: 227.19
- EINECS:
- MDL Number:MFCD11641438
- Synonyms:1-[3-(Trifluoromethyl)phenyl]-1H-pyrazol-5-amine;2-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine;1H-Pyrazol-5-amine, 1-[3-(trifluoromethyl)phenyl]-
4 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
Package
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01EXB5
- Product description2-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine 95%
- Packaging100mg
- Price$240
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01EXB5
- Product description2-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine 95%
- Packaging250mg
- Price$407
- Updated2026-05-30
- Buy
- ManufacturerChemenu
- Product numberCM376908
- Product description1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine 95%+
- Packaging1g
- Price$488
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11057732
- Product description1-(3-(Trifluoromethyl)phenyl)-1H-pyrazol-5-amine 97%
- Packaging1g
- Price$436
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01EXB5 | 2-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine 95% | 100mg | $240 | 2026-05-30 | Buy |
| aablocks | AA01EXB5 | 2-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine 95% | 250mg | $407 | 2026-05-30 | Buy |
| Chemenu | CM376908 | 1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine 95%+ | 1g | $488 | 2026-05-26 | Buy |
| Crysdot | CD11057732 | 1-(3-(Trifluoromethyl)phenyl)-1H-pyrazol-5-amine 97% | 1g | $436 | 2026-05-26 | Buy |
Properties
Boiling point :325.2±42.0 °C(Predicted)
Density :1.39±0.1 g/cm3(Predicted)
pka :2.75±0.50(Predicted)
Density :1.39±0.1 g/cm3(Predicted)
pka :2.75±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




